Cybin (TSE:CYBN) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Cybin Inc., a leading neuropsychiatry company, is set to join the Water Tower Research Fireside Chat Series to discuss promising data from its Phase II study on major depressive disorder and the upcoming Phase III PARADIGM program. The company’s innovative treatments aim to revolutionize mental healthcare, addressing significant unmet needs with long-lasting results.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
